Adage Capital Management
Adage Capital is a Boston-based hedge fund founded by Phillip Gross which held nearly $24 billion in securities at the end of the quarter ended September 30, 2010.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
View Older Stories View More Recent Stories
-
Immunic Highlights 2023 Accomplishments and Upcoming Milestones
-
Immunic Inc. (IMUX) Announces $240M Private Placement
-
Immunic, Inc. Announces Private Placement of up to $240 Million
-
Form SC 13G VERU INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Werewolf Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Syros Pharmaceuticals (SYRS) Prices $45M Share and Warrant Offering at $4.42/sh
-
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Form SC 13G Compass Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Arvinas Inc. (ARVN) Announces Oversubscribed $350M Share and Warrant Placement at $21.36/sh
-
Arvinas Announces Oversubscribed $350 Million Private Placement
-
Form SC 13G Aeva Technologies, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
ValueAct builds stake in Disney, adds drama at home of Mickey Mouse -sources
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Sep 30
-
Form 13F-NT Adage Capital Management For: Sep 30
-
Aeva Reports Third Quarter 2023 Results
-
Form SC 13G Nkarta, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
HawkEye 360 Closes Additional $10 Million in Series D-1 Funding from Lockheed Martin Ventures and Company Insiders
-
Form SC 13G SOLENO THERAPEUTICS INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G SUTRO BIOPHARMA, INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Opti
-
Soleno Therapeutics (SLNO) Prices 3M Share Offering at $20/sh; Concurrent Private Placement
-
Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
-
Form SC 13G CymaBay Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Verastem, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Benitec Biopharma Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
AN2 Therapeutics Announces Pricing of $70.0 Million Underwritten Offering of Common Stock
-
Tudor, Adage Capital among hedge funds making bets on NYC office space
-
Form 13F-NT Adage Capital Management For: Jun 30
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Jun 30
-
Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update
-
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
-
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering
-
Benitec Biopharma (BNTC) Prices 15.54M Share Offering at $1.93/sh
-
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
-
Gracell Biotechnologies (GRCL) Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
-
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
-
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
-
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
-
Form SC 13G/A GCM Grosvenor Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Molecular Templates, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
HawkEye 360 Receives $58 Million in Series D-1 Funding to Introduce a New Satellite Architecture and Accelerate Data Science Efforts
-
Molecular Templates (MTEM) Announces Up to $40 Million Private Placement Offering of Common Stock, Warrants
-
Molecular Templates Announces Up to $40 Million Private Placement Offering
-
Savara (SVRA) Prices 21M Share Offering at $3/sh
-
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Form SC 13G/A ABEONA THERAPEUTICS INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Abeona Therapeutics (ABEO) Announces $25 Million Registered Direct Offering of Common Stock, Warrants
-
Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

